Vasopressin and methylprednisolone for in-hospital cardiac arrest — Protocol for a randomized, double-blind, placebo-controlled trial

Objective: To describe the clinical trial “Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest” (VAM-IHCA). Methods: The VAM-IHCA trial is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of vasopressin and methylpr...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lars W. Andersen, Birthe Sindberg, Mathias Holmberg, Dan Isbye, Jesper Kjærgaard, Stine T. Zwisler, Søren Darling, Jacob Moesgaard Larsen, Bodil S. Rasmussen, Bo Løfgren, Kasper Glerup Lauridsen, Kim B. Pælestik, Christoffer Sølling, Anders G. Kjærgaard, Dorte Due-Rasmussen, Fredrik Folke, Mette Gitz Charlot, Kasper Iversen, Martin Schultz, Sebastian Wiberg, Rikke Malene H.G. Jepsen, Tobias Kurth, Michael Donnino, Hans Kirkegaard, Asger Granfeldt
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2021-03-01
Col·lecció:	Resuscitation Plus
Matèries:	In-hospital cardiac arrest Vasopressin Methylprednisolone Randomized trial
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666520421000060
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!